荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

未开盘 12-12 16:08:09

20.680

-0.180

-0.86%

最高21.060	最低20.340	成交量7.48万
今开20.880	昨收20.860	日振幅3.45%
总市值46.74亿	流通市值46.74亿	总股本2.26亿
成交额154.92万	换手率0.03%	流通股本2.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":20.68,"timestamp":1765526889006,"preClose":20.86,"halted":0,"volume":74800,"delay":0,"floatShares":225999999,"shares":225999999,"eps":-1.687207181396399,"marketStatus":"未开盘","change":-0.18,"latestTime":"12-12 16:08:09","open":20.88,"high":21.06,"low":20.34,"amount":1549232,"amplitude":0.034516,"askPrice":20.86,"askSize":200,"bidPrice":20.68,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-0.9527934729057521,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":0,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":20.86,"openAndCloseTimeList":[[1765503000000,1765512000000],[1765515600000,1765526400000]],"volumeRatio":0.27440458243998556,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509/wiki","defaultTab":"wiki","newsList":[{"id":"2590598728","title":"荃信生物-B(02509.HK)再涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590598728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590598728?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:48","pubTimestamp":1765439282,"startTime":"0","endTime":"0","summary":"每经AI快讯，荃信生物-B(02509.HK)再涨超3%，截至发稿涨3.26%，报20.9港元，成交额306.19万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512113588839439.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512113588839439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2590275560","title":"港股异动 | 荃信生物-B(02509)再涨超3% 双抗矩阵布局在海外正式迈入临床阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2590275560","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590275560?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:29","pubTimestamp":1765438197,"startTime":"0","endTime":"0","summary":"消息面上，荃信生物宣布，12月8日，公司收到合作伙伴Caldera Therapeutics, Inc支付的500万美元里程碑付款，此付款是基于QX030N/CLD-423获得人类研究伦理委员会I期临床试验伦理许可而触发的。据悉，公司自主研发的双抗QX030N/CLD-423于澳大利亚通过HREC审批，计划于2026年初启动临床试验。本次许可标志着公司的双抗矩阵布局在海外正式迈入临床阶段，将进一步强化公司在自免及过敏疾病领域的领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2590598846","title":"每日卖空追踪 | 荃信生物-B 12月10日卖空量成交1.14万股，卖空比例为4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590598846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590598846?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355431,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月10日，涨0.6%，卖空量成交1.14万股，较上一交易日减少34.48%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016345795353d58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016345795353d58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2590982371","title":"港股荃信生物-B涨近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590982371","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590982371?lang=zh_cn&edition=full","pubTime":"2025-12-10 10:23","pubTimestamp":1765333414,"startTime":"0","endTime":"0","summary":"每经AI快讯，荃信生物-B(02509.HK)涨近4%，截至发稿涨3.98%，报20.92港元，成交额167.04万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512103587474051.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512103587474051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2590534839","title":"荃信生物-B(02509)：QX030N于澳大利亚的I期临床试验获得人类研究伦理委员会许可及收到里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2590534839","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590534839?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:18","pubTimestamp":1765279102,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 公布，于2025年12月8日，公司收到合作伙伴Caldera Therapeutics, Inc.支付的500万美元里程碑付款，该付款乃基于QX030N/CLD-423*获得人类研究伦理委员会I期临床试验伦理许可而触发。近日，公司自主研发的双抗QX030N/CLD-423于澳大利亚通过HREC审批，计划于2026年初启动临床试验。据悉，公司与Caldera于2025年4月23日签署对外授权协议，Caldera获得QX030N/CLD-423的全球独家开发和商业化权利。截至2025年12月8日，公司已获得预付款及里程碑款共计1500万美元，以及Caldera一定比例的股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379484.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2590896392","title":"荃信生物-B12月08日遭主力抛售60.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590896392","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590896392?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181758,"startTime":"0","endTime":"0","summary":"12月08日, 荃信生物-B股价跌3.72%，报收20.18元，成交金额462.9万元，换手率0.10%，振幅4.58%，量比0.98。荃信生物-B今日主力资金净流出60.5万元，上一交易日主力净流出28.5万元。该股近5个交易日下跌7.09%，主力资金累计净流入66.4万元；近20日主力资金累计净流入144.5万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162147a72aa71e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208162147a72aa71e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2589381614","title":"荃信生物-B12月05日主力净流出28.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381614","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589381614?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:15","pubTimestamp":1764922542,"startTime":"0","endTime":"0","summary":"12月05日, 荃信生物-B股价跌0.76%，报收20.96元，成交金额522.8万元，换手率0.11%，振幅10.70%，量比1.18。荃信生物-B今日主力资金净流出28.5万元，上一交易日主力净流出0万元。该股近5个交易日下跌6.93%，主力资金累计净流入127.0万元；近20日主力资金累计净流入142.7万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161908979178d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205161908979178d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2588987002","title":"每日卖空追踪 | 荃信生物-B 12月04日卖空量成交2600股，卖空比例为1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588987002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588987002?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837032,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月04日，涨2.13%，卖空量成交2600股，较上一交易日减少59.38%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163510978f8851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163510978f8851&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2588073803","title":"【读财报】港股11月回购透视：合计回购超117亿港元 德康农牧、粉笔等年内首度回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2588073803","media":"面包财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588073803?lang=zh_cn&edition=full","pubTime":"2025-12-04 07:30","pubTimestamp":1764804600,"startTime":"0","endTime":"0","summary":"港股上市公司11月回购总额117.42亿港元根据信披数据，2025年11月港股共有99家上市公司发起回购，累计回购7.12亿股，回购金额合计达117.42亿港元，较去年同期的206.29亿港元下降43.08%。此外，中国飞鹤、德康农牧、粉笔等公司于11月首度进行年内回购或明显加大回购力度。2025年前11月，小米集团合计回购30.38亿港元。11月，德康农牧进行年内首次港股回购，金额为5906.38万港元，回购数量为79.76万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204073045a72259e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204073045a72259e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01919","02509","06186","02586","02419","09886","02469","01810","03888","01931"],"gpt_icon":0},{"id":"2588720156","title":"荃信生物-B(02509)12月1日斥资196.12万港元回购9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588720156","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588720156?lang=zh_cn&edition=full","pubTime":"2025-12-01 21:04","pubTimestamp":1764594275,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，该公司于2025年12月1日斥资196.12万港元回购9万股股份，每股回购价格为21.58-22港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2588870950","title":"每日卖空追踪 | 荃信生物-B 12月01日卖空量成交1.26万股，卖空比例为5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588870950","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588870950?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577830,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间12月01日，跌3.55%，卖空量成交1.26万股，较上一交易日减少35.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163418a71c71c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201163418a71c71c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2587731228","title":"每日卖空追踪 | 荃信生物-B 11月28日卖空量成交1.04万股，卖空比例为6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2587731228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587731228?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:30","pubTimestamp":1764318629,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间11月28日，跌0.27%，卖空量成交1.04万股，较上一交易日减少53.57%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164430a4bffbd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128164430a4bffbd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2586218130","title":"港股异动 | 荃信生物-B(02509)涨超7% 月内回购超1800万港元 QX027N获得两项临床试验默示许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2586218130","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586218130?lang=zh_cn&edition=full","pubTime":"2025-11-27 11:14","pubTimestamp":1764213265,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荃信生物-B(02509)早盘涨超7%，截至发稿，涨4.97%，报21.98港元，成交额856.48万港元。消息面上，荃信生物发布公告，11月25日，公司耗资47.3万港元回购2.3万股。数据显示，公司本月连续回购股份，累计增持90.18万股，累计金额达1824.07万港元。此外，荃信生物近日宣布，公司自主研发的长效双抗QX027N注射液获得国家药品监督管理局药品审评中心的临床试验默示许可，拟用于治疗哮喘及特应性皮炎。该候选药物的临床许可标志着公司在自免及过敏疾病领域的创新双抗矩阵正式迈入临床阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2586830792","title":"智通港股回购统计|11月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2586830792","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586830792?lang=zh_cn&edition=full","pubTime":"2025-11-26 09:10","pubTimestamp":1764119401,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量101.40 万，回购金额6.36 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00975","00434","02235","00386","00366","01497","00909","02018","02416","02419","02469","02886","09878","02343","01588","HTCD.SI","03798","01519","00947","02273","02319","00418","00700","01066","09669","09896","02038","00103","06186","02251","06098","09959","09886","01651","01931","01681","02869","TCHmain","00777","06826","06868","XIACY","01919","02509","02005","81810","09923","02392","02039","01810"],"gpt_icon":1},{"id":"2586436427","title":"荃信生物-B(02509)11月25日斥资47.27万港元回购2.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586436427","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586436427?lang=zh_cn&edition=full","pubTime":"2025-11-25 19:54","pubTimestamp":1764071689,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2025年11月25日斥资47.27万港元回购2.32万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2586406886","title":"每日卖空追踪 | 荃信生物-B 11月25日卖空量成交1.06万股，卖空比例为3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586406886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586406886?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:30","pubTimestamp":1764059429,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间11月25日，跌0.2%，卖空量成交1.06万股，较上一交易日增加231.25%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125163434a4b8fe21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125163434a4b8fe21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"gpt_icon":0},{"id":"2585177194","title":"荃信生物董秘胡衍保：中国创新药企将持续出海资本市场回报可期｜聚焦2025华夏大健康","url":"https://stock-news.laohu8.com/highlight/detail?id=2585177194","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585177194?lang=zh_cn&edition=full","pubTime":"2025-11-22 22:22","pubTimestamp":1763821355,"startTime":"0","endTime":"0","summary":"11月21日，以“智领健康未来”为主题的2025华夏大健康产业发展暨康复服务大会在北京召开。作为连续四届引领行业风向的标杆盛会，科技与创新始终是贯穿全程的灵魂主线。在圆桌会议上，荃信生物董事会秘书胡衍保在一场行业交流活动中分享了公司的发展历程与战略布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511223572077833.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511223572077833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","06978","159992","02509","BK1574"],"gpt_icon":0},{"id":"1128733548","title":"江蘇荃信（02509）回购4.92万股股份，总额约99.82万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128733548","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128733548?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:31","pubTimestamp":1763731912,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司（02509）于2025年11月21日发布翌日披露报表，公告在香港联交所回购49,200股H股，占当日前已发行股份（不含库存股）约0.0217%。回购价格区间为每股19.96港元至20.60港元，合计支付约998,154.84港元。回购后公司已发行股份（不含库存股）数量变动至226,193,000股，库存股份增至878,600股。\n公司已于2025年6月20日通过回购授权，授权总额为22,207,160股，截至目前合计回购878,600股。公司确认本次交易已遵守香港联交所上市规则及相关法律程序。公告由董事会秘书和联席公司秘书胡衍保签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"gpt_icon":0},{"id":"2585503145","title":"荃信生物-B(02509)11月21日斥资99.82万港元回购4.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585503145","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585503145?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:27","pubTimestamp":1763731664,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2025年11月21日斥资99.82万港元回购4.92万股股份。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02509","BK1161"],"gpt_icon":0},{"id":"2584794423","title":"荃信生物-B(02509)11月19日斥资199.62万港元回购9.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584794423","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584794423?lang=zh_cn&edition=full","pubTime":"2025-11-19 21:57","pubTimestamp":1763560630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2025年11月19日，该公司斥资199.62万港元回购9.72万股H股股份，每股回购价20.38-20.7港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":0.0884},{"period":"3month","weight":-0.3414},{"period":"6month","weight":0.2368},{"period":"1year","weight":1.3473},{"period":"ytd","weight":1.8022}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":-0.0351},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0872},{"period":"1year","weight":0.2736},{"period":"ytd","weight":0.295}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}